When you consider this came from research that was funded by Jawbone, Eight and that the author has equity in InCarda, it makes me question the authenticity of their claims. Can someone from this field corroborate what is claimed?
The review by Dr. Marcus, a cardiologist [1], refers to a study funded by Apple and published in The New England Journal of Medicine [2]. His main point is that “insufficient evidence exists to recommend atrial fibrillation (AF) screening in asymptomatic adults.” [3] There would be a significant number of alarmed users with false-positive results who would undergo costly additional evaluation and treatment where there may be of little benefit. It is troublesome, in his view, that “private industry has bypassed expert consensus to initiate screening for AF in the general population.” He adds that “this is an industry instigated inversion of the relationship between patients and physicians...” [4] Larry Husten at the Cardiobrief blog gives a good overview of some of the pitfalls [5].
Mr Huston in the last link is complaining that there were too many subjects in the test and that the test was pretty expensive for Apple. How am I to take this seriously? It’s just another Apple hater.
This is my humble opinion, but all doctor talk of "inversion of the relationship between patients and physicians" is complete quackery. We will see medicine change for the better over the next 10 years, but it will be a long road. First step is competition in medical education.
vo2maxer|6 years ago
[1] https://profiles.ucsf.edu/gregory.marcus
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa1901183
[3] https://jamanetwork.com/journals/jama/fullarticle/2695678
[4] https://www.nature.com/articles/s41569-019-0330-y
[5] http://www.cardiobrief.org/2019/11/13/what-can-we-learn-from...
tinus_hn|6 years ago
whelsemin|6 years ago